These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 2863777)
1. The effect of milenperone on the aggressive behavior of psychogeriatric patients. A double-blind placebo-controlled study. De Cuyper H; van Praag HM; Verstraeten D Neuropsychobiology; 1985; 13(1-2):1-6. PubMed ID: 2863777 [TBL] [Abstract][Full Text] [Related]
2. The effect of milenperone on the aggressive behavior of oligophrenic patients. A double-blind placebo-controlled study. De Cuyper H; van Praag HM; Verstraeten D Neuropsychobiology; 1985; 13(3):101-5. PubMed ID: 3900796 [TBL] [Abstract][Full Text] [Related]
3. Milenperone. A selective drug for the control of behavioral disorders in epileptic and alcoholic patients. Gelders YG; Reyntjens AJ; Aerts TJ Acta Psychiatr Belg; 1984; 84(2):151-9. PubMed ID: 6146246 [TBL] [Abstract][Full Text] [Related]
4. Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study. Nygaard H; Bakke K; Brudvik E; Lien GK; Moe TJ; Elgen K Pharmatherapeutica; 1988; 5(3):152-8. PubMed ID: 2896359 [TBL] [Abstract][Full Text] [Related]
5. Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study. Fuglum E; Schillinger A; Andersen JB; Belstad BE; Jensen D; Müller F; Müller KJ; Schulstad B; Elgen K Pharmatherapeutica; 1989; 5(5):285-91. PubMed ID: 2568639 [TBL] [Abstract][Full Text] [Related]
6. Pipothiazine palmitate in the management of aggressive mentally handicapped patients. Lynch DM; Eliatamby CL; Anderson AA Br J Psychiatry; 1985 May; 146():525-9. PubMed ID: 2861874 [TBL] [Abstract][Full Text] [Related]
8. Withdrawal of neuroleptic medications from institutionalized dementia patients: results of a double-blind, baseline-treatment-controlled pilot study. Bridges-Parlet S; Knopman D; Steffes S J Geriatr Psychiatry Neurol; 1997 Jul; 10(3):119-26. PubMed ID: 9322135 [TBL] [Abstract][Full Text] [Related]
9. Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial. Sival RC; Haffmans PM; Jansen PA; Duursma SA; Eikelenboom P Int J Geriatr Psychiatry; 2002 Jun; 17(6):579-85. PubMed ID: 12112183 [TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients. Krakowski MI; Czobor P; Nolan KA J Clin Psychopharmacol; 2008 Oct; 28(5):485-93. PubMed ID: 18794642 [TBL] [Abstract][Full Text] [Related]
11. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine. Buckley PF; Paulsson B; Brecher M J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. Schneider LS; Tariot PN; Dagerman KS; Davis SM; Hsiao JK; Ismail MS; Lebowitz BD; Lyketsos CG; Ryan JM; Stroup TS; Sultzer DL; Weintraub D; Lieberman JA; N Engl J Med; 2006 Oct; 355(15):1525-38. PubMed ID: 17035647 [TBL] [Abstract][Full Text] [Related]
13. A double-blind pilot study of risperidone in the treatment of conduct disorder. Findling RL; McNamara NK; Branicky LA; Schluchter MD; Lemon E; Blumer JL J Am Acad Child Adolesc Psychiatry; 2000 Apr; 39(4):509-16. PubMed ID: 10761354 [TBL] [Abstract][Full Text] [Related]
14. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506 [TBL] [Abstract][Full Text] [Related]
15. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia. Woods SW; Gueorguieva RV; Baker CB; Makuch RW Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728 [TBL] [Abstract][Full Text] [Related]
16. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD). Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416 [TBL] [Abstract][Full Text] [Related]
18. Aggression and psychopharmacological treatments in major psychosis and personality disorders during hospitalisation. Mauri MC; Rovera C; Paletta S; De Gaspari IF; Maffini M; Altamura AC Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1631-5. PubMed ID: 21620921 [TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of aggressive behavior. Pabis DJ; Stanislav SW Ann Pharmacother; 1996 Mar; 30(3):278-87. PubMed ID: 8833564 [TBL] [Abstract][Full Text] [Related]
20. Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior. Dorevitch A; Katz N; Zemishlany Z; Aizenberg D; Weizman A Am J Psychiatry; 1999 Jan; 156(1):142-4. PubMed ID: 9892313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]